Port Erin Biopharma Investments Ltd (LSE:PEBI) - Overview

Stock Report

Port Erin Biopharma Investments Ltd PEBI

Last Price
GBX8.00

Day Change
0.00|0.00%

As of 05/12/2016
13:19:50 GMT | GBX
Minimum 15 Minutes Delay.

Last Close8.00p
Day Range7.50 - 7.50
Mkt Cap1.86Mil
52-Wk Range3.90 - 10.00
Yield %0.00
ISINIM00B6QH1J21
Volume19,185
P/E-3.94
P/S-12.40
P/CF-2.95

Share Price

Total Returns 02/12/2016

 Chg (%)  
More ...
Port Erin Biopharma Investments Ltd33.33 
FTSE 100 TR GBP-1.21
 
Financials
201320142015
More ...
Income Statement
Turnover0.592.10-0.19
Operating Profit0.411.38-0.60
Net Profit0.421.38-0.60
Reported EPS1.254.08-2.03
Balance Sheet
Current Assets3.635.382.72
Non Current Assets0.000.000.00
Total Assets3.635.382.72
Current Liabilities0.030.400.03
Total Liabilities0.030.400.03
Total Equity3.604.982.69
Cash Flow
Operating Cash Flow-0.10-0.27-0.80
Net Change in Cash0.47-0.09-0.31
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------

Company Profile

Port Erin Biopharma Investments Ltd invests in biopharmaceutical sector. Its objective is to create value for shareholders through investing in companies that have potential to generate substantial revenues through development of biopharmaceutical drugs.
 

Sector

Biotechnology

Market Position

1777 of 1865 Companies

Index

FTSE AIM All Share

Outlook

(17/03/2016) no outlook statement

Next Event 22/12/2016

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)0.0013.1416.27
Div Yld (E)0.004.184.36
PEG (E)0.000.360.00
ROCE-22.41206.9680.66
Op Mrgn315.71-17.09-14.86
EPS Grwth0.009.6525.03
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanJim Mellon
Finance DirectorMr. Denham Eke
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.